Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial.

Teut M, Dahler J, Hirschberg U, Luedtke R, Albrecht H, Witt CM.

Trials. 2013 Apr 5;14:96. doi: 10.1186/1745-6215-14-96.

2.

Protocol for a phase 1 homeopathic drug proving trial.

Teut M, Hirschberg U, Luedtke R, Schnegg C, Dahler J, Albrecht H, Witt CM.

Trials. 2010 Jul 22;11:80. doi: 10.1186/1745-6215-11-80.

3.

Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study.

Walach H, Sherr J, Schneider R, Shabi R, Bond A, Rieberer G.

Homeopathy. 2004 Oct;93(4):179-85.

PMID:
15532695
4.

A homoeopathic proving of Galphimia glauca.

Teut M, Dahler J, Schnegg C; Wilsede Study Group for Homoeopathic Provings.

Forsch Komplementmed. 2008 Aug;15(4):211-7. doi: 10.1159/000148825. Epub 2008 Aug 15.

PMID:
18787330
5.

Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.

Brien S, Lewith G, Bryant T.

Br J Clin Pharmacol. 2003 Nov;56(5):562-8. Erratum in: Br J Clin Pharmacol. 2004 Jan;57(1):117.

6.
7.
8.

A minimum protocol for randomised homeopathic drug proving as basis for further research.

Jansen JP, Jong M, Hildingsson I, Jong MC.

Forsch Komplementmed. 2014;21(4):232-8. doi: 10.1159/000366042. Epub 2014 Aug 21.

PMID:
25231564
9.

A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: comparing two high potencies.

Möllinger H, Schneider R, Löffel M, Walach H.

Forsch Komplementarmed Klass Naturheilkd. 2004 Oct;11(5):274-80.

PMID:
15572868
10.

HIV Nosode: The Homeopathic Pathogenetic Trial.

Shah R.

Forsch Komplementmed. 2015;22(3):156-62. doi: 10.1159/000435845. Epub 2015 Jun 23.

PMID:
26335635
11.

The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment.

Walach H, Köster H, Hennig T, Haag G.

J Psychosom Res. 2001 Mar;50(3):155-60.

PMID:
11316508
12.

Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.

Brien S, Lachance L, Prescott P, McDermott C, Lewith G.

Rheumatology (Oxford). 2011 Jun;50(6):1070-82. doi: 10.1093/rheumatology/keq234. Epub 2010 Nov 13.

15.

Double-blind, placebo-controlled homeopathic pathogenetic trials: symptom collection and analysis.

Dominici G, Bellavite P, di Stanislao C, Gulia P, Pitari G.

Homeopathy. 2006 Jul;95(3):123-30.

PMID:
16815514
17.

Classical and new proving methodology: provings of Plumbum metallicum and Piper methysticum and comparison with a classical proving of Plumbum metallicum.

Signorini A, Lubrano A, Manuele G, Fagone G, Vittorini C, Boso F, Vianello P, Rebuffi A, Frongia T, Rocco V, Pichler C.

Homeopathy. 2005 Jul;94(3):164-74.

PMID:
16060202
18.

Scientific proving of ultra high dilutions on humans.

Walach H, Teut M.

Homeopathy. 2015 Oct;104(4):322-7. doi: 10.1016/j.homp.2015.08.008. Epub 2015 Oct 12. Review.

PMID:
26678737
19.

Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design.

Bell IR, Lewis DA 2nd, Brooks AJ, Schwartz GE, Lewis SE, Caspi O, Cunningham V, Baldwin CM.

J Altern Complement Med. 2004 Apr;10(2):269-83.

PMID:
15165408
20.

Supplemental Content

Support Center